G

Genedrive PLC
LSE:GDR

Watchlist Manager
Genedrive PLC
LSE:GDR
Watchlist
Price: 2.275 GBX -9% Market Closed
Market Cap: 12.4m GBX
Have any thoughts about
Genedrive PLC?
Write Note

Genedrive PLC
Investor Relations

Genedrive Plc is a holding company, which engages in the development of drugs and disease diagnostics. The Company’s Genedrive device is a molecular diagnostics platform for the diagnosis of infectious diseases and for use in patient stratification (genotyping), pathogen detection and other indications. The Company’s commercial products include Genedrive MT-RNR1, Genedrive BioPlex, Genedrive HCV ID Kit and Genedrive 96 SARS-CoV-2 Ki. Genedrive MT-RNR1 is a commercial test for antibiotic induced hearing loss. Genedrive BioPlex is developed for the determination of military biothreats from pathogens. Genedrive HCV ID Kit is effective in the diagnosis of Hepatitis C Virus (HCV) infection in resource limited settings. Genedrive 96 SARS-CoV-2 Ki is a plate format of a COVID-19 molecular test for high throughput use, which detects all known variants of COVID-19.

Show more

Earnings Calls

No Earnings Calls Available

Management

Mr. Russell John Shaw
CFO, Secretary & Director
No Bio Available
Dr. Gino Miele Ph.D.
CEO, Chief Scientific Officer & Executive Director
No Bio Available

Contacts

Address
MANCHESTER
48 Grafton Street
Contacts
+441619890245.0
www.genedriveplc.com